2023
DOI: 10.1016/j.athoracsur.2022.01.026
|View full text |Cite
|
Sign up to set email alerts
|

Open, Video- and Robot-Assisted Thoracoscopic Lobectomy for Stage II-IIIA Non-Small Cell Lung Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(17 citation statements)
references
References 12 publications
1
16
0
Order By: Relevance
“…Due to the relatively short duration that RATL has been applied for NSCLC, its long-term oncological efficacies have been reported by a mere few studies. Yang et al and Shagabayeva et al found that RATL achieved a similar 5-year survival to VATL and OL for stage I and II-IIIA NSCLC, respectively [ 41 , 42 ]. Meanwhile, Herb et al reported that RATL offered a long-term advantage over OL for clinical-N2 NSCLC patients, while a prospective study reported by Huang et al did not show such superiority [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…Due to the relatively short duration that RATL has been applied for NSCLC, its long-term oncological efficacies have been reported by a mere few studies. Yang et al and Shagabayeva et al found that RATL achieved a similar 5-year survival to VATL and OL for stage I and II-IIIA NSCLC, respectively [ 41 , 42 ]. Meanwhile, Herb et al reported that RATL offered a long-term advantage over OL for clinical-N2 NSCLC patients, while a prospective study reported by Huang et al did not show such superiority [ 14 , 15 ].…”
Section: Discussionmentioning
confidence: 99%
“…The advantages of minimally invasive and robotic surgery have been widely discussed in the literature, and at present, robotic lobectomy is recognized as being a feasible and safe approach [2][3][4][5], with clinical outcomes similar, or in some cases superior, to those of video-assisted thoracoscopic surgery (VATS) [6][7][8][9], even in advanced stages (II-IIIA NSCLC) [10].…”
Section: Introductionmentioning
confidence: 99%
“…At present, robotic lobectomy is considered an achievable and safe procedure [ 2 , 3 , 4 , 5 ], with clinical and oncological outcomes comparable to those of video-assisted thoracoscopic surgery (VATS)/thoracotomy, both in early [ 6 , 7 , 8 , 9 ] and in advanced stages (II-IIIA NSCLC) with no differences in medium and long-term survival [ 10 ].…”
Section: Introductionmentioning
confidence: 99%